Beacon Biosignals Named in Fast Company's Most Innovative Companies of 2026!

Our mission at Beacon has always been to accelerate drug development for unmet medical needs to get life-changing treatments to patients faster. Recognition like this helps bring awareness to the tireless and world-class work of our Beacon employees and the exponential progress we've made in recent years.

Through our work supporting clinical trials across CNS disease, deepening the understanding of neurological conditions, and building the world's largest database of validated sleep EEG data, we are fundamentally changing how these conditions are diagnosed and treated for billions of patients worldwide.

Last year, we closed an $86M Series B, expanded our $109M partnership with Takeda, and acquired CleveMed's home sleep testing technology. We have even more news coming out in 2026.

Say hello to Waveband!

New name, same FDA 510(k) clearance.

The Dreem 3S EEG headband is now called Waveband, delivering the same trusted technology used by the world’s best companies. Contact us to learn how Waveband can support your clinical trial today.

Share this post:

Say hello to Waveband!

New name, same FDA 510(k) clearance.

The Dreem 3S EEG headband is now called Waveband, delivering the same trusted technology used by the world’s best companies. Contact us to learn how Waveband can support your clinical trial today.

Say hello to Waveband!

New name, same FDA 510(k) clearance.

The Dreem 3S EEG headband is now called Waveband, delivering the same trusted technology used by the world’s best companies. Contact us to learn how Waveband can support your clinical trial today.

Say hello to Waveband!

New name, same FDA 510(k) clearance.

The Dreem 3S EEG headband is now called Waveband, delivering the same trusted technology used by the world’s best companies. Contact us to learn how Waveband can support your clinical trial today.